|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Epidemiology and Cancer Control |
Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL 60612 (P.J.J., B.J.M., T.S.S., S.F., F.G.D.); and Central Brain Tumor Registry of the United States, Chicago, IL 60632 (P.J.J., B.J.M., T.S.S., S.F., F.G.D.)
2 Address correspondence and reprint requests to Bridget J. McCarthy, Division of Epidemiology and Biostatistics (M/C 922), School of Public Health, University of Illinois at Chicago, 2121 W. Taylor St., Chicago, IL 60612-7260.
Abstract
Brain tumor incidence has increased over the last 20 years in all age groups, both overall and for specific histologies. Reasons attributed to these increases include increase in lymphoma due to HIV/AIDS, introduction of computed tomography/magnetic resonance imaging, and changes in coding/classification. The purpose of this study was to describe overall and histologic-specific incidence trends in a population-based series of primary benign and malignant brain tumors. Data from the Central Brain Tumor Registry of the United States from 1985 through 1994 were used to determine incidence trends in the broad age groups 0-19, 20-64, and 65 years, both overall and for selected histologies. Poisson regression was used to express trends as average annual percentage change. Overall, incidence increased modestly (annual percentage change 0.9%, 95% confidence interval, 0.4, 1.4). When lymphomas were excluded, this result was not statistically significant (annual percentage change 0.5%, 95% confidence interval, 0.1, 1.1). Specific histologies that were increasing were lymphomas in individuals aged 20 to 64 years and in males aged 65 years or older, ependymomas in the population aged 20 to 64 years, nerve sheath tumors in males, and pituitary tumors in females. Increases that were not specific to any population subgroup were seen for glioblastoma, oligodendrogliomas, and astrocytomas, excluding not otherwise specified (NOS) tumors. Corresponding decreases were noted for NOS, astrocytoma NOS, and glioma NOS. Increasing incidence trends for lymphomas were consistent with previous literature. Improvements in diagnostic technology in addition to changes in classification and coding were likely to be responsible for decreases seen in incidence of NOS subgroups and corresponding increases in glioma subgroups. In contrast, the increases identified for ependymomas, nerve sheath tumors, and pituitary tumors were less likely to be artifacts of improvements in diagnosis, and they warrant further study.
References
Ahsan, H., Neugut, A.I., and Bruce, J.N. (1995) Trends
in incidence of primary malignant brain tumors in USA, 1981-1990.
Int. J. Epidemiol. 24,1078
-1085.
Anderson, R.N., and Rosenberg, H.M. (1998) Age standardization of death rates: Implementation of the year 2000 standard. Natl. Vital Stat. Rep. 47, 1-16, 20.[Medline]
Anonymous (1998) Of mobile phones and morbidity. Environ. Health Perspect. 106,A474 -A475.[ISI][Medline]
Bahemuka, M., Massey, E.W., and Schoenberg, B.S.
(1988) International mortality from primary nervous system
neoplasms: Distribution and trends. Int. J. Epidemiol.
17, 33-38.
Blair, V., and Birch, J.M. (1994) Patterns and temporal trends in the incidence of malignant disease in children. II. Solid tumours of childhood. Eur. J. Cancer 30A,1498 -1511.[CrossRef]
Bunin, G.R., Feuer, E.J., Witman, P.A., and Meadows, A.T. (1996) Increasing incidence of childhood cancer: Report of 20 years experience from the Greater Delaware Valley Pediatric Tumor Registry. Pediatr. Perinat. Epidemiol. 10,319 -338.[ISI][Medline]
Cairncross, J.G., Macdonald, D.R., and Ramsay, D.A. (1992) Aggressive oligodendroglioma: A chemosensitive tumor. Neurosurgery 31,78 -82.[ISI][Medline]
Cote, T.R., Manns, A., Hardy, C.R., Yellin, F.J., and Hartge, P.
(1996) Epidemiology of brain lymphoma among people with or
without acquired immunodeficiency syndrome. AIDS/Cancer Study Group.
J. Natl. Cancer Inst.
88,675
-679.
Cunningham, J., Ries, L., Hankey, B., Seiffert, J., Lyles, B., Shambaugh, E., Percy, C., and Van Holten, V. (1992)The SEER Program Code Manual. Revised Edition . Bethesda, Md: National Cancer Institute, National Institutes of Health.
Davis, D.L., and Schwartz, J. (1988) Trends in cancer mortality: US white males and females, 1968-83. Lancet. 1,633 -636.[ISI][Medline]
Davis, D.L., Ahlbom, A., Hoel, D., and Percy, C. (1991) Is brain cancer mortality increasing in industrialized countries. Am. J. Ind. Med. 19,421 -431.[ISI][Medline]
Davis, F.G., Malinski, N., Haenszel, W., Chang, J., Flannery, J., Gershman, S., Dibble, R., and Bigner, D.D. (1996) Primary brain tumor incidence rates in four United States regions, 1985-1989: A pilot study. Neuroepidemiology 15,103 -112.[CrossRef][ISI][Medline]
Davis, F.G., Bruner, J.M., and Surawicz, T.S. (1997) The rationale for standardized registration and reporting of brain and central nervous system tumors in population-based cancer registries. Neuroepidemiology 16,308 -316.[CrossRef][ISI][Medline]
Desmeules, M., Mikkelsen, T., and Mao, Y. (1992)
Increasing incidence of primary malignant brain tumors: Influence of
diagnostic methods. J. Natl. Cancer Inst.
84,442
-445.
Eby, N.L., Grufferman, S., Flannelly, C.M., Schold, S.C., Jr., Vogel, F.S., and Burger, P.C. (1988) Increasing incidence of primary brain lymphoma in the US. Cancer 62,2461 -2465.[CrossRef][ISI][Medline]
EDITS [computer program] (1997) Version 2.00. Atlanta, Ga: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention.
Esteve, J., Benhamou, E., and Raymond, L. (1994) Statistical Methods in Cancer Research. Volume IV. Descriptive Epidemiology. Lyon: International Agency for Research on Cancer.
Forman, A.D. (1999) Re: Trends in reported incidence
of primary malignant brain tumors in children in the United States.
J. Natl. Cancer Inst.
91,648
-649.
Gibson, R.M., Levit, K.R., Lazenby, H., and Waldo, D.R. (1984) National health expenditures, 1983. Health Care Financing Rev. 6,1 -29.
Greig, N.G., Ries, L.G., Yancik, R., and Rapoport, S.I.
(1990) Increasing annual incidence of primary malignant brain
tumors in the elderly. J. Natl. Cancer Inst.
82,1621
-1624.
Gurney, J.G., Davis, S., Severson, R.K., Fang, J.Y., Ross, J.A., and Robison, L.L. (1996) Trends in cancer incidence among children in the US. Cancer 78,532 -541.[CrossRef][ISI][Medline]
Helseth, A. (1995) The incidence of primary central nervous system neoplasms before and after computerized tomography availability. J. Neurosurg. 83,999 -1003.[ISI][Medline]
Hjalmers, U., Kulldorff, M., Wahlqvist, Y., and Lannering, B. (1999) Increased incidence rates but no space-time clustering of childhood astrocytoma in Sweden, 1973-1992. Cancer 85,2077 -2090.[ISI][Medline]
Kleihues, P., Burger, P.C., and Scheithauer, B.W. (1993a) Histological Typing of Tumours of the Central Nervous System. Second edition. Berlin: Springer-Verlag.
Kleihues, P., Burger, P.C., and Scheithauer, B.W. (1993b) The new WHO clas sification of brain tumors. Brain Pathol. 3,255 -268.[ISI][Medline]
La Vecchia, C., and Decarli, A. (1985) Trends in cancer mortality in Italy, 1955-1978. Tumori 71,201 -218.[ISI][Medline]
Legler, J.M., Gloeckler Ries, L.A., Smith, M.A., Warren, J.L.,
Heineman, E.F., Kaplan, R.S., and Linet, M.S. (1999) Brain and
other central nervous system cancers: Recent trends in incidence and
mortality. J. Natl. Cancer Inst.
91,1382
-1390.
Lutz, J.M., and Coleman, M.P. (1994) Trends in primary cerebral lymphoma. Br. J. Cancer 70,716 -718.[ISI][Medline]
Mao, Y., Desmeules, M., Semenciw, R.M., Hill, G., Gaudette, L., and Wigle, D.T. (1991) Increasing brain cancer rates in Canada. Can. Med. Assoc. J. 145,1583 -1591.[Abstract]
McKinney, P.A., Ironside, J.W., Harkness, E.F., Arango, J.C., Doyle, D., and Black, R.J. (1994) Registration quality and descriptive epidemiology of childhood brain tumours in Scotland 1975-90. Br. J. Cancer 70,973 -979.[ISI][Medline]
Modan, B., Wagener, D.K., Feldman, J.J., Rosenberg, H.M., and
Feinleib M. (1992) Increased mortality from brain tumors: A
combined outcome of diagnostic technology and change of attitude toward the
elderly. Am. J. Epidemiol.
135,1349
-1357.
Mosso, M.L., Colombo, R., Giordano, L., Pastore, G., Terracini, B., and Magnani, C. (1992) Childhood Cancer Registry of the province of Torino, Italy: Survival, incidence, and mortality over 20 years. Cancer 69,1300 -1306.[CrossRef][ISI][Medline]
Paleologos, N.A., Macdonald, D.R., Vick, N.A., and Cairncross, J.G.
(1999) Neoadjuvant procarbazine, CCNU, and vincristine for
anaplastic and aggressive oligodendroglioma. Neurology
53,1141
-1143.
Percy, C., Van Holten, V., and Muir, C.S. (Eds.) (1990) International Classification of Diseases for Oncology. Second edition. Geneva: World Health Organization.
Polednak, A.P. (1991) Time trends in incidence of
brain and central nervous system cancers in Connecticut. J. Natl.
Cancer Inst. 83,1679
-1681.
Polednak, A.P., and Flannery, J.T. (1995) Brain, other central nervous system, and eye cancer. Cancer 75,330 -337.[CrossRef][ISI][Medline]
Preston-Martin, S., Thomas, D.C., Wright, W.E., and Henderson, B.E. (1989) Noise trauma in the aetiology of acoustic neuromas in men in Los Angeles County, 1978-1985. Br. J. Cancer 59,783 -786.[ISI][Medline]
Radhakrishnan, K., Mokri, B., Parisi, J.E., O'Fallon, W.M., Sunku, J., and Kurland, L.T. (1995) The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann. Neurol. 37,67 -73.[CrossRef][ISI][Medline]
SAS Technical Report P-243, SAS/STAT Software: The GENMOD Procedure, Release 6.09. (1993) Cary, N.C.: SAS Institute.
Schoenberg, B.S., Christine, B.W., and Whisnat, J.P.
(1976) The descriptive epidemiology of primary intracranial
neoplasms: The Connecticut experience. Am. J.
Epidemiol. 104,499
-510.
Smith, M.A., Freidlin, B., Gloeckler Ries, L.A., and Simon, R.
(1998) Trends in reported incidence of primary malignant brain
tumors in children in the United States. J. Natl. Cancer
Inst. 90,1269
-1277.
Steinberg, E.P. (1986) The status of MRI in 1986: Rates of adoption in the United States and elsewhere. Am. J. Roentgenol. 147,435 -455.
Steinberg, E.P., Sisk, J.E., and Locke, K.E. (1985) X-ray CT and magnetic resonance imagers: Diffusion patterns and policy issues. N. Engl. J. Med. 313,859 -864.[ISI][Medline]
Surawicz, T.S., McCarthy, B.J., Kupelian, V., Jukich, P.J., Bruner, J.M., Davis, F.G., and the collaborating registries of the Central Brain Tumor Registry of the United States (1999) The descriptive epidemiology of primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro-Oncology [serial on line], Doc. #98-13, January 19, 1999. URL neuro-oncology.mc.duke.edu. Neuro-Oncol. 1,14 -25.[Abstract]
Surawicz, T.S., McCarthy, B.J., Jukich, P.J., and Davis, F.G. (2000) The accuracy and completeness of primary brain and central nervous system tumor data: Results from the Central Brain Tumor Registry of the United States. J. Registry Manag. 27, 51-55.
Surveillance, Epidemiology, and End Results (SEER) (1997) U.S. Populations, 1973-1996. Bethesda, Md.: National Cancer Institute, November 11, 1997. URL www.seer.ims.nci.nih.gov.
Varner, A. (1999) Re: Trends in reported incidence of
primary malignant brain tumors in children in the United States. J.
Natl. Cancer Inst. 91,973
-974.
Velema, J.P., and Percy, C.L. (1987) Age curves of central nervous system tumor incidence in adults: Variation of shape by histologic type. J. Natl. Cancer Inst. 79,623 -629.
Werner, M.H., Phuphanich, S., and Lyman, G.H. (1995) The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer 76,1634 -1642.[CrossRef][ISI][Medline]
This article has been cited by other articles:
|
|
 |
|
  D. Provost, A. Cantagrel, P. Lebailly, A. Jaffre, V. Loyant, H. Loiseau, A. Vital, P. Brochard, and I. Baldi Brain tumours and exposure to pesticides: a case-control study in southwestern France Occup. Environ. Med., August 1, 2007; 64(8): 509 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-T. Tran, M. Uhl, J. Y. Ma, L. Janssen, V. Sriram, S. Aulwurm, I. Kerr, A. Lam, H. K. Webb, A. M. Kapoun, et al. Inhibiting TGF-{beta} signaling restores immune surveillance in the SMA-560 glioma model Neuro-oncol, July 1, 2007; 9(3): 259 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Propp, B. J. McCarthy, F. G. Davis, and S. Preston-Martin Descriptive epidemiology of vestibular schwannomas Neuro-oncol, January 1, 2006; 8(1): 1 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hoffman, J. M. Propp, and B. J. McCarthy Temporal trends in incidence of primary brain tumors in the United States, 1985-1999 Neuro-oncol, January 1, 2006; 8(1): 27 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Koeller and E. J. Rushing From the Archives of the AFIP: Oligodendroglioma and Its Variants: Radiologic-Pathologic Correlation RadioGraphics, November 1, 2005; 25(6): 1669 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Huang, E. A. Whelan, A. M. Ruder, E. M. Ward, J. A. Deddens, K. E. Davis-King, T. Carreon, M. A. Waters, M. A. Butler, G. M. Calvert, et al. Reproductive Factors and Risk of Glioma in Women Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1583 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Fang, M. Kulldorff, and D. I. Gregorio Brain cancer mortality in the United States, 1986 to 1995: A geographic analysis Neuro-oncol, July 1, 2004; 6(3): 179 - 187. [Abstract] [PDF]
|
|
|
|
 |
|
 C. A. Lipinski, N. L. Tran, C. Bay, J. Kloss, W. S. McDonough, C. Beaudry, M. E. Berens, and J. C. Loftus Differential Role of Proline-Rich Tyrosine Kinase 2 and Focal Adhesion Kinase in Determining Glioblastoma Migration and Proliferation Mol. Cancer Res., March 1, 2003; 1(5): 323 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wrensch, Y. Minn, T. Chew, M. Bondy, and M. S. Berger Epidemiology of primary brain tumors: Current concepts and review of the literature Neuro-oncol, October 1, 2002; 4(4): 278 - 299. [Abstract] [PDF]
|
|
|
|
|
|
F. G. Davis, V. Kupelian, S. Freels, B. McCarthy, and T. Surawicz Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups Neuro-oncol, July 1, 2001; 3(3): 152 - 158. [Abstract] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
